LEXICON PHARMACEUTICALS INC (LXRX)       2.02  -0.11 (-5.16%)

2.02  -0.11 (-5.16%)

US5288723027 - Common Stock - After market: 2.02 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -0.13 -0.14 0.018.53% Q2 2022 -0.16 -0.16 0.000.30% Q1 2022 -0.16 -0.17 0.014.74% Q4 2021 -0.17 -0.19 0.028.76% Q3 2021 -0.16 -0.18 0.0211.38% Q2 2021 -0.13 -0.16 0.0320.22% Q1 2021 -0.15 -0.16 0.016.57% Q4 2020 -0.04 -0.28 0.2485.82%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.62 -0.61 -1.16%Q4 2022 -0.15 -0.17 14.40%FY 2023 -0.64 -0.62 -4.19%Q1 2023 -0.14 -0.16 10.75%Q2 2023 -0.20 -0.16 -27.50%Q3 2023 -0.21 -0.13 -64.77%Q4 2023 -0.19 -0.15 -33.17%FY 2024 -0.02 -0.64 96.77%FY 2025 -0.03 -0.02 -43.43%FY 2026 -0.04 -0.03 -46.29%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 39K 51K -12K-23.53% Q2 2022 35K 51K -16K-31.37% Q1 2022 37K 51K -14K-27.45% Q4 2021 14K 14K∞% Q3 2021 23K 23K∞% Q2 2021 234K 9.18K 224.82K2,449.02% Q1 2021 1.71M -1.71M-100.00% Q4 2020 200K 112.2K 87.8K78.25%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 150.96K 298K -49.34%Q4 2022 51K 14K 264.29%FY 2023 19.645M 150.96K 12,913.38%Q1 2023 37K -100.00%Q2 2023 35K -100.00%Q3 2023 7.131M 39K 18,184.62%Q4 2023 21.391M 51K 41,843.14%FY 2024 142.28M 19.645M 624.26%FY 2025 7.221B 142.28M 4,975.20%FY 2026 190.513B 7.221B 2,538.32%